EN 
ES
PT
TH
DE
TR
FR
Ailewu AQ UG
Bi-iṣẹ ẹjẹ glukosi ati eto mimojuto uric acid; Aifọwọyi awọn ila ejection; ISO15197 2013 fọwọsi; Koodu smart fun idanwo uric acid
Akopọ
Ailewu AQ UG Glucose Ẹjẹ ati Eto Abojuto Acid Acid ti ṣe apẹrẹ fun wiwọn titobi ti glucose ati uric acid ni awọn ayẹwo ẹjẹ ẹjẹ ẹjẹ tuntun ati ninu awọn ayẹwo ẹjẹ gbogbo iṣan. Ailewu AQ UG Glucose Ẹjẹ ati Uric Acid Monitoring System jẹ fun lilo ni ita ara nikan (ni lilo iwadii aisan in vitro) fun idanwo ara ẹni ati lilo ọjọgbọn bi iranlọwọ ninu iṣakoso ọgbẹ ati hyperuricemia (HUA).
Specification
| Iṣe Idanwo | Ẹjẹ Glucose | Uric Acid |
|---|---|---|
| igbeyewo ọna | FAD-GDH | Oxidized Ferrocene Itọsẹ |
| Iru apẹẹrẹ | Ẹsẹ keekeeke odidi ẹjẹ / ẹjẹ gbogbo iṣan | Ẹsẹ keekeeke odidi ẹjẹ / ẹjẹ gbogbo iṣan |
| Ẹjẹ ẹjẹ | 0.6µl | 3µl |
| Ipele idanwo | 20-600mg / dL (1.1-33.3mmol / L) | 3.0-20.0mg / dL （181-1188 olmol / L） |
| Akoko Idanwo | 5s | 25 |
| Memory | 500 tosaaju | 100 tosaaju |
| Wiwulo rinhoho | 24 osu | 12 osu |
Evalu Iṣiro iṣẹ olumulo glukosi:
| Awọn abajade fun awọn ifọkansi glucose <100 mg / dL (<5.55mmol / l) | ||
|---|---|---|
| Laarin ± 5mg / dL (laarin ± 0.28mmol / l) | Laarin ± 10mg / dL (laarin ± 0.56mmol / l) | Laarin ± 15mg / dL (laarin ± 0.83mmol / l) |
| 50% (14/28) | 85.71% (24 / 28) | 100% (28 / 28) |
| Awọn abajade fun awọn ifọkansi glucose ≥ 100 mg / dL (≥5.55mmol / l) | ||
| Laarin ± 5% | Laarin ± 10% | Laarin ± 15% |
| 55.56% (40/72) | 90.28% （65/72) | 97.22% (70/72) |
Evalu Imọye iṣe olumulo olumulo Uric acid:
| Awọn abajade fun awọn ifọkansi uric acid <297μmol / L (5.0 mg / dL) | ||
|---|---|---|
| Laarin ± 14.9μmol / L (Laarin ± 0.3 mg / dL) | Laarin ± 29.7μmol / L (Laarin ± 0.5 mg / dL) | Laarin ± 59.4μmol / L (Laarin ± 1.0 mg / dL) |
| 40.0% (6/15) | 60.0% (9 / 15) | 100% (15 / 15) |
| Awọn abajade fun awọn ifọkansi uric acid≥ 297μmol / L (5.0 mg / dL) | ||
| Laarin ± 5% 57.6% (49/85) | Laarin ± 10% 94.1% （80/85) | Laarin ± 15% 100% (85/85) |
Pe wa